Investigating the Selectivity of Allosteric Inhibitors for Mutant T790M EGFR over Wild Type Using Molecular Dynamics and Binding Free Energy Calculations

Similar Items

• Prediction of activity and selectivity profiles of human Carbonic Anhydrase inhibitors using machine learning classification models
  by: Annachiara Tinivella, et al.
  Published: (2021-03-01)
• Mutational monitoring of EGFR T790M in cfDNA for clinical outcome prediction in EGFR-mutant lung adenocarcinoma.
  by: Kang-Yi Su, et al.
  Published: (2018-01-01)
• Autophagosome-mediated EGFR down-regulation induced by the CK2 inhibitor enhances the efficacy of EGFR-TKI on EGFR-mutant lung cancer cells with resistance by T790M.
  by: Kwang Sup So, et al.
  Published: (2014-01-01)
• A case report of EGFR mutant lung adenocarcinoma that acquired resistance to EGFR-tyrosine kinase inhibitors with T790M mutation and epithelial-to-mesenchymal transition
  by: Nana Zhang, et al.
  Published: (2017-01-01)
• Development of new mouse lung tumor models expressing EGFR T790M mutants associated with clinical resistance to kinase inhibitors.
  by: Lucia Regales, et al.
  Published: (2007-08-01)